Varenicline

被引:0
|
作者
Raymond Niaura
Carole Jones
Peter Kirkpatrick
机构
[1] Butler Hospital,the Department of Psychiatry and Human Behavior
[2] IMS Health,undefined
[3] Nature Reviews Drug Discovery,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Varenicline tartrate (Chantix; Pfizer), an α4β2 nicotinic receptor partial agonist, was approved by the US FDA as an aid to smoking cessation treatment in May 2006.
引用
收藏
页码:537 / 538
页数:1
相关论文
共 50 条
  • [21] Varenicline (Chantix) revisited
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2007, 49 (1274): : 96 - 96
  • [22] Exacerbation of schizophrenia by varenicline
    Freedman, Robert
    AMERICAN JOURNAL OF PSYCHIATRY, 2007, 164 (08): : 1269 - 1269
  • [23] Varenicline and proximal myopathy
    Wood, Shelley E.
    Fegan, P. Gerry
    MEDICAL JOURNAL OF AUSTRALIA, 2009, 190 (11) : 655 - 655
  • [24] Varenicline: cardiovascular safety
    Samuels, Larry
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (12)
  • [25] Varenicline Induced Psychosis
    Annagur, Bilge Burcak
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 22 (01): : 110 - 111
  • [26] Varenicline for Tobacco Dependence
    Hays, J. Taylor
    Ebbert, Jon O.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (19): : 2018 - 2024
  • [27] An efficient synthesis of varenicline
    Pasikanti, Srinivas
    Reddy, D. Srinivasa
    Venkatesham, B.
    Dubey, P. K.
    Iqbal, Javed
    Das, Parthasarathi
    TETRAHEDRON LETTERS, 2010, 51 (01) : 151 - 152
  • [28] Varenicline: quantifying the risk
    Blankfield, Robert P.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (12) : 1404 - 1404
  • [30] Varenicline: Implications for the Field
    Bobak, Alex
    JOURNAL OF SMOKING CESSATION, 2007, 2 : 8 - 11